Compare Stocks

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ANTH Anthera Pharmaceuticals		$0.00	$0.00 ▼ $0.01	N/A	1.13	N/A	N/A
SKBI Skystar Bio-Pharmaceutical		$0.00	$0.00 ▼ $0.01	$1K	-175.12	1,983 shs	25 shs
SPHS Sophiris Bio		$0.00	$0.00 ▼ $0.05	$4K	1.94	N/A	N/A
VRSEF Verisante Technology	$0.01	$0.01	$0.00 ▼ $0.02	$192K	18.96	750 shs	N/A

10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ANTH Anthera Pharmaceuticals	0.00%	0.00%	0.00%	0.00%	0.00%
SKBI Skystar Bio-Pharmaceutical	0.00%	0.00%	0.00%	0.00%	0.00%
SPHS Sophiris Bio	0.00%	0.00%	0.00%	0.00%	0.00%
VRSEF Verisante Technology	0.00%	0.00%	-50.00%	-42.53%	-19.35%

You’re invited: Biggest crypto event of 2024 (Ad)

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ANTH Anthera Pharmaceuticals	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SKBI Skystar Bio-Pharmaceutical	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SPHS Sophiris Bio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
VRSEF Verisante Technology	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ANTH Anthera Pharmaceuticals	N/A	N/A	N/A	N/A
SKBI Skystar Bio-Pharmaceutical	N/A	N/A	N/A	N/A
SPHS Sophiris Bio	N/A	N/A	N/A	N/A
VRSEF Verisante Technology	N/A	N/A	N/A	N/A

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ANTH Anthera Pharmaceuticals	N/A	N/A	N/A	N/A	N/A	N/A
SKBI Skystar Bio-Pharmaceutical	N/A	N/A	N/A	N/A	N/A	N/A
SPHS Sophiris Bio	N/A	N/A	N/A	N/A	N/A	N/A
VRSEF Verisante Technology	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ANTH Anthera Pharmaceuticals	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SKBI Skystar Bio-Pharmaceutical	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SPHS Sophiris Bio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
VRSEF Verisante Technology	-$70K	N/A	∞	N/A	N/A	N/A	-243.49%	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ANTH Anthera Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
SKBI Skystar Bio-Pharmaceutical	N/A	N/A	N/A	N/A	N/A
SPHS Sophiris Bio	N/A	N/A	N/A	N/A	N/A
VRSEF Verisante Technology	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ANTH Anthera Pharmaceuticals	N/A	N/A	N/A
SKBI Skystar Bio-Pharmaceutical	N/A	N/A	N/A
SPHS Sophiris Bio	N/A	N/A	N/A
VRSEF Verisante Technology	N/A	1.40	1.40

Ownership

Institutional Ownership

Company	Institutional Ownership
ANTH Anthera Pharmaceuticals	N/A
SKBI Skystar Bio-Pharmaceutical	N/A
SPHS Sophiris Bio	N/A
VRSEF Verisante Technology	N/A

Insider Ownership

Company	Insider Ownership
ANTH Anthera Pharmaceuticals	2.08%
SKBI Skystar Bio-Pharmaceutical	19.80%
SPHS Sophiris Bio	4.50%
VRSEF Verisante Technology	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
ANTH Anthera Pharmaceuticals	21	N/A	N/A	Not Optionable
SKBI Skystar Bio-Pharmaceutical	318	8.70 million	N/A	Not Optionable
SPHS Sophiris Bio	2,018	35.55 million	N/A	Not Optionable
VRSEF Verisante Technology	N/A	38.34 million	N/A	Not Optionable

SPHS, ANTH, SKBI, and VRSEF Headlines

Source	Headline
	Verisante Technology, Inc. Announces Exchange Acceptance of Shares for Debt Transaction accesswire.com - March 30 at 6:30 AM
	Verisante: Q4 Earnings Snapshot sfgate.com - March 29 at 6:07 AM
	Verisante Technology, Inc. Announces Shares for Debt Agreements accesswire.com - March 14 at 5:20 PM
	Verisante Technology, Inc. Announces 2023 AGM Results finance.yahoo.com - December 21 at 5:26 AM
	Verisante Technology, Inc. Announces Exchange Approval for Shares for Debt Transaction finance.yahoo.com - October 5 at 11:09 PM
	Verisante Technology Inc. Announces Shares for Debt Agreements finance.yahoo.com - September 8 at 3:42 AM
	Verisante: Q2 Earnings Snapshot wtop.com - August 15 at 9:14 PM
	Latest Technology News prweek.com - March 30 at 2:19 PM
	Verisante Technology, Inc. Announces Exchange Acceptance for Shares for Debt Transactions finance.yahoo.com - November 23 at 6:55 PM
	Verisante: Q3 Earnings Snapshot sfgate.com - November 18 at 9:42 AM
	Verisante Technology, Inc.: Verisante Technology Inc. Announces Proposed Shares for Debt Transaction finanznachrichten.de - October 22 at 9:24 AM
	Verisante Technology Inc. Announces Proposed Shares for Debt Transaction finance.yahoo.com - October 19 at 6:38 PM
	Verisante Technology Inc. Announces Closing Non-Brokered Private Placement apnews.com - July 13 at 7:05 PM
	Verisante Technology, Inc. Announces AGM Results apnews.com - July 7 at 11:10 PM
	Verisante Technology, Inc.: Verisante Technology Inc. Announces Non-Brokered Private Placement finanznachrichten.de - June 30 at 8:19 PM
	Verisante Technology Inc. Announces Non-Brokered Private Placement bignewsnetwork.com - June 30 at 8:19 PM
	Verisante Share Consolidation Effective finance.yahoo.com - June 23 at 5:29 PM
	VERISANTE ANNOUNCES SHARE CONSOLIDATION finance.yahoo.com - June 14 at 6:45 PM
	VERISANTE TECHNOLOGY INC. ANNOUNCES SHARE ISSUANCE finance.yahoo.com - June 6 at 4:39 AM
	Verisante: Q1 Earnings Snapshot apnews.com - May 31 at 4:48 PM
	IIROC Trading Resumption - VRS.H finance.yahoo.com - May 30 at 6:41 PM
	VERISANTE ANNOUNCES REINSTATEMENT TO TRADE AND CORPORATE UPDATE finance.yahoo.com - May 27 at 11:31 PM
	Verisante Technology Inc (VRSEF) nasdaq.com - January 23 at 8:37 PM
	Verisante Technology Dividend Per Share (TTM) ycharts.com - December 19 at 12:06 AM

New MarketBeat Followers Over Time

Company Descriptions

Anthera Pharmaceuticals

OTCMKTS:ANTH

Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy. The company has license agreements with Amgen, Inc., and Eli Lilly and Company. Anthera Pharmaceuticals, Inc. was founded in 2004 and is based in Houston, Texas.

Skystar Bio-Pharmaceutical

OTCMKTS:SKBI

Skystar Bio-Pharmaceutical Company researches, develops, produces, markets, and sells veterinary healthcare and medical care products in the People's Republic of China. The company offers micro-organism products, veterinary medicines for poultry and livestock, feed additives, and bio-pharmaceutical veterinary vaccines. It markets its products through distributers and franchise distributors, as well as directly to customers. The company is headquartered in Xi'an, the People's Republic of China.

Sophiris Bio

OTCMKTS:SPHS

Sophiris Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products for the treatment of urological diseases. The company was founded by James L. Heppell in May 2003 and is headquartered in La Jolla, CA.

Verisante Technology

OTCMKTS:VRSEF

Verisante Technology Inc. does not have significant operations. Previously, it was involved in the design and manufacture of innovative cancer diagnostic devices. The company was formerly known as T-Ray Science Inc. and changed its name to Verisante Technology Inc. in January 2011. Verisante Technology Inc. was incorporated in 2006 and is based in Vancouver, Canada.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial